Clinical Trials Directory

Trials / Unknown

UnknownNCT03016520

Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers

An Open-label, Randomized, Single-dose, 2-way Crossover Study to Compare the Pharmacokinetics and Safety of DWJ1392 and DWC20164 in Healthy Male Volunteers

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
28 (estimated)
Sponsor
Daewoong Pharmaceutical Co. LTD. · Industry
Sex
Male
Age
19 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study to Compare the safety and pharmacokinetics of DWJ1392 and DWC20164 in healthy male volunteers.

Conditions

Interventions

TypeNameDescription
DRUGDWJ1392
DRUGDWC20164

Timeline

Start date
2017-01-09
Primary completion
2017-01-26
Completion
2017-03-01
First posted
2017-01-10
Last updated
2017-02-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03016520. Inclusion in this directory is not an endorsement.